Cuorips Inc. (TSE: 4894)
Health Care · Biotechnology · JP
¥6,310.00
+0.80% today · -5.7% 1Y
Cuorips Inc. (TSE: 4894) operates in the Biotechnology industry within the Health Care sector. The company is valued at $353.89M and employs 51 people.
Over the last twelve months the share price has lost 5.7%, trading between 3.61K and 12.40K.
Tweenvest scores Cuorips Inc. across four factors: quality 42/100, value 49/100. Its strongest factor is value.
4894 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $353.89M
- Revenue (TTM)
- $787.47K
- P/E
- —
- EPS
- -138.16
- Dividend yield
- —
- Beta (5Y)
- 0.78
- 52-week high
- ¥12,400.00
- 52-week low
- ¥3,610.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.88M
- Employees
- 51
- Next earnings
- —
About Cuorips Inc.
Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived cardiomyocyte sheets, undertaking their research, development, production, commercialization, and distribution. The firm's portfolio extends to include cellular, tissue-based, and cell processing products. Furthermore, it offers contract development and manufacturing services, alongside expert consulting. The company, which was incorporated in 2017 and is based in Tokyo, Japan, previously operated under the name Cuore Inc. before adopting Cuorips Inc. in June 2017.
- ISIN
- JP3266030000
- Founded
- 2017
- Listed since
- Jun 27, 2023
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PureTech Health plcLSE: PRTC | $360.13M | £1.13 | +1.44% |
| Inhibikase Therapeutics, Inc.NasdaqCM: IKT | $358.69M | $1.85 | -6.35% |
| Enanta Pharmaceuticals, Inc.NasdaqGS: ENTA | $358.24M | $12.30 | -1.60% |
| Emergent BioSolutions Inc.NYSE: EBS | $357.89M | $6.98 | -1.13% |
| Jiangsu CoWin Biotech Co., Ltd.SHSE: 688426 | $353.03M | CN¥21.51 | -4.74% |
| Jiangsu Gdk Biological Technology Co., LtdSHSE: 688670 | $352.60M | CN¥19.17 | +2.35% |
| BioDlink International Company LimitedSEHK: 1875 | $350.57M | HK$3.56 | -4.30% |
| Surrozen, Inc.NasdaqCM: SRZN | $348.96M | $24.76 | -16.60% |
Figures last refreshed Oct 11, 2026.